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Background: Atherosclerosis , the principal cause of death in Western countries, 
is a kind of cardiovascular diseases which seriously threatens the public health. It 
accounts for 50% of mortality in the USA, Europe and Japan. In China, with the 
development of economy and the changes in diet, the incidence of atherosclerosis is 
rising by years . Therefore, more and more focus have been put on searching for new 
drugs of atheroclerosis. 
The development of atherosclerosis is a complex process, and there is no target 
for atherosclerosis has been determined. PPAR-α has become an important research 
target of atherosclerosis due to its regulation of endothelial function, lipid metabolism 
and inflammation ,since these processes are closely related to development of 
atherosclerosis. The exsited PPAR-α synthesis ligands have become first-line drugs 
for clinical treatment of cardiocascular disease. Therefore, endogenous PPAR-α 
ligand oleoyethanolamide (OEA) has its potential for a anti-atherosclerosis drugs. 
Purpose: The purpose of our study is to investigate the effects of OEA on  
atherosclerosis response and to explain the mechanism .  
Methods: Human umbilical vein endothelial cells(HUVECs) were separated and 
cultured in vitro; MTT assay was used to detect the cytoactive of HUVECs; HUVECs 
and RAW 246.7 cells treated with ox-LDL were used to induce necrosis and 
inflammation, respectively. HUVECs apoptosis was detected by AnnexinⅤ/PI-FTIC 
staining and flow cytometer. The expression level of mRNA and protein were 
detected by quantitative real-time PCR ,western blotting and  ELISA.  
Results: Data showed that, in HUVEC cells, OEA inhibits apootosis induced by 
ox-LDL through activation of PPAR-α and SIRT-1 expression. In RAW 246.7 cells, 
OEA decreased the expression levels of inflammatory cytokines, including TNF-α 
and CRP, and pro-atherosclerosis factor, M-CSF. Furthermore, OEA treatment 
reversed the expression of SIRT-1, which was suppressed by ox-LDL. 
Conclusion：The data suggests that OEA played a certain role on atherosclerosis 
through activation of PPAR-α and anti-inflammatory pathway. 
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第一章 前言 
1.1 PPAR-α概述 





















































































和布洛芬也可与 PPAR-α 结合，它们主要是通过与 PPAR-α 结合后下调环氧化酶
2(CoX-2)的表达和活性而实现抗炎作用。还有许多 PPAR-α合成配体正处于实验




氧合酶途径合成的衍生物 8-S 羟基二十碳四烯酸(8S-HETE)和白三烯 B4(LTB4)于
PPAR-α的亲合力比脂肪酸本身还高。它激活 PPAR-α，可刺激过氧化物酶体对白









































































图 1.2 PPAR-α配体结构 
Fig.1.2 Structures of PPAR-α ligands 
由于 PPAR-α的重要作用，其合成和天然配体已经成为药物研究中关注的热
点。许多科学家都开始了对 PPAR-α 的研究，现已发现的 PPAR-α 的激动剂及其















- 5 -  
表 1.1 PPAR-α的激动剂的半数有效浓度(EC50) 
Table1.1 EC50 of PPAR-α agonists 
化合物名称 EC50(μM) Ref. 
氯贝特 50 14 
非诺贝特 18 14 
苯扎贝特 90 14 
WY-14653 0.63 14 
GW-7647 0.006 15 
GW-9578 0.005 14 
8(S)-HETE 0.2 16 
EPA 10 17 
油酸 10 18 
亚油酸 7 19 
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